marketnews

Attention Farfetch Limited Investors: Don’t Miss the Deadline for Securities Class Action – Rosen National Trial Lawyers Urges You to Secure Counsel Now!

marketnews02 mins

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Farfetch Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – FTCH NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Farfetch Limited (NYSE: FTCH) between March 9, 2023 and August…

Read More

5 Tips to Keep Your Family Healthy When Illness Strikes: A Guide to Preventing the Spread of Colds and Flu

marketnews04 mins

Stopping the Spread: How to Contain Colds and Flu When Illness Hits Home As winter nears, many families grapple with containing sickness when it strikes their household. Fevers, coughs, congestion and fatigue spread insidiously among loved ones, often despite best efforts. When seasonal maladies hit, what measures work to curb transmission inside four walls? As…

Read More

Civil Society Budget Advocacy Group Partners with MUBS to Promote Renewable Energy

marketnews05 mins

Civil Society Budget Advocacy Group Partners With MUBS To Promote Renewable Energy Partnership to Address Environmental Degradation Civil Society Budget Advocacy Group (CSBAG) has recently announced a strategic partnership with Makerere University Business School (MUBS) to promote renewable energy generation as a solution to mitigate environmental degradation. The partnership was unveiled by CSBAG Executive Director,…

Read More

Breaking News: Celularity Inc. Receives Nasdaq Notice for Delayed Form 10-Q Filing

marketnews04 mins

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing Overview On November 24, 2023, Celularity Inc. (Nasdaq: CELU) disclosed that they had received a notification from the Nasdaq Stock Market LLC regarding a late Form 10-Q filing. The company, known for its development of allogeneic cell therapies and biomaterial products, shared the…

Read More

Gain Therapeutics: Celebrating the Successful Closing of $10.1 Million Public Offering and Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

marketnews06 mins

The Exciting News from Gain Therapeutics, Inc. A New Chapter in the Company’s Growth November 24, 2023 Today, Gain Therapeutics, Inc. has made a significant announcement that marks a new chapter in its growth and development. The company has successfully closed an underwritten public offering, raising a total of $10.1 million through the sale of…

Read More